At the end of May, global health leaders came together in Geneva for the World Health Assembly. Lasting over a week, this is an annual opportunity for discussion, progress updates and priority-setting for some of the most important issues in global health.
This year, meningitis was on the agenda. As we approach the mid-point of the World Health Organization’s Global Road Map to Defeat Meningitis by 2030 – first approved at the World Health Assembly in 2020 – this was an important moment for assessing progress on our collective goal to defeat meningitis by the end of the decade.
Almost 40 governments, including the UK, took part in the discussion by making statements about their national progress, regional commitments, and what more they feel needs to be done to tackle meningitis.

© World Health Organization/Pierre Albouy
Access to vaccines was a key issue raised by multiple countries. Sudan, on behalf of countries in the Eastern Mediterranean region, highlighted the absence of meningitis vaccines across the region in comparison to other communicable diseases like influenza. A number of countries celebrated the Men5 vaccine, whose introduction WHO supported in Nigeria and Niger last year and encouraged wider rollout to save more lives.